申请人:Merrell Dow Pharmaceuticals Inc.
公开号:US05472959A1
公开(公告)日:1995-12-05
The invention relates to compounds of the formula ##STR1## wherein B.sub.1 and B.sub.2 are each independently hydrogen; hydroxy; --OR.sub.2 wherein R.sub.2 is a C.sub.1 -C.sub.4 alkyl or an Ar--Y group wherein Ar is aryl and Y is a hydrogen or C.sub.1 -C.sub.4 alkyl; or, where B.sub.1 and B.sub.2 are attached to adjacent carbon atoms, B.sub.1 and B.sub.2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; A is a bond, methylene or oxygen, sulfur, NR.sub.4 or NCOR.sub.5 wherein R.sub.4 is hydrogen, a C.sub.1 -C.sub.4 alkyl or an Ar--Y-- group and R.sub.5 is --CF.sub.3, a C.sub.1 -C.sub.10 alkyl or an Ar--Y-- group; R.sub.3 is hydrogen or --CH.sub.2 OC(O)C(CH.sub.3).sub.3 ; R.sub.1 is hydrogen, C.sub.1 -C.sub.4 alkyl or --CH.sub.2 OC(O)--C(CH.sub.3).sub.3 ; and n is an integer 1 to 3, that are useful as inhibitors of enkephalinase and ACE.
本发明涉及式子##STR1##的化合物,其中B.sub.1和B.sub.2分别独立地为氢; 羟基; --OR.sub.2,其中R.sub.2是C.sub.1-C.sub.4烷基或Ar--Y基团,其中Ar是芳基,Y是氢或C.sub.1-C.sub.4烷基; 或者,当B.sub.1和B.sub.2附加在相邻的碳原子上时,B.sub.1和B.sub.2可以与所述相邻碳原子一起取代成苯环或亚甲二氧基; A是键,亚甲基或氧,硫,NR.sub.4或NCOR.sub.5,其中R.sub.4是氢,C.sub.1-C.sub.4烷基或Ar--Y--基团,R.sub.5是--CF.sub.3,C.sub.1-C.sub.10烷基或Ar--Y--基团; R.sub.3是氢或--CH.sub.2OC(O)C(CH.sub.3).sub.3; R.sub.1是氢,C.sub.1-C.sub.4烷基或--CH.sub.2OC(O)--C(CH.sub.3).sub.3; n是1到3的整数,这些化合物对于脑啡肽酶和ACE的抑制剂是有用的。